Prevention of skin cancer by phytochemicals via Nrf2 and epigenetics
通过 Nrf2 和表观遗传学使用植物化学物质预防皮肤癌
基本信息
- 批准号:9207083
- 负责人:
- 金额:$ 35.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-01-13 至 2020-12-31
- 项目状态:已结题
- 来源:
- 关键词:AgarAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsBCL2 geneBackBenchmarkingBerryBiological MarkersCarcinogenicity TestsCell LineCellsChemopreventive AgentClinical TrialsCoupledCyclin D1DNA MethylationDevelopmentDietDietary PhytochemicalDiseaseEarEdemaEmbryoEnvironmental CarcinogensEnzymesEpigenetic ProcessEventExposure toFibroblastsFutureGenesGoalsHealthcareHumanIn VitroIncidenceInflammationInflammatoryInflammatory ResponseInvestigationKnock-outKnowledgeLaboratoriesMEKsMalignant NeoplasmsMediatingMethylationModelingModificationMolecularMorbidity - disease rateMusOxidative RegulationOxidative StressPapillomaPathogenesisPathway interactionsPhytochemicalPlayPrevalencePrevention strategyPreventiveProcessProteinsPublishingRegimenRoleSkinSkin CancerSkin CarcinogenesisSkin CarcinomaSkin NeoplasmsSulforaphaneSunlightTestingTranscriptional ActivationTumor PromotionUVB carcinogenesisUVB inducedUltraviolet B RadiationUnited StatesVascular Endothelial Growth Factorsbasebeta cateninc-myc Genescancer chemopreventioncancer typecare burdendimethylbenzanthraceneepigenetic markerepigenetic regulationepigenomicsgenome wide methylationin vivoin vivo Modelinsightkeratinocytemouse modelnovelpreventprotective effectpublic health relevanceskin cancer preventionsuccesstranscription factortumorigenesisursolic acid
项目摘要
DESCRIPTION (provided by applicant): Non-melanoma skin cancers are the most common types of cancers in the United States, with over 1 million new cases per year, while increasing exposure to sunlight (UV) and environmental carcinogens appear to be the major causative factors. The long term goal of this application is to develop a safe and effective strategy using relatively non-toxic dietary cancer chemopreventive compounds to prevent skin cancer. The rationale for these studies is based on investigation from our laboratory and others, showing that: (1) Sulforaphane (SFN) presents abundantly in these berries and crucifers, respectively, strongly inhibits skin carcinogenesis in various mouse models in vivo; (2) Skin carcinogenesis is greatly enhanced in knockouts of Nrf2, a transcription factor critical in mediating anti-oxidative stress/inflammatory responses, and, importantly, SFN has no cancer protective effect in these Nrf2(-/-) mice; (3) Nrf2 and Nrf2-targeted HO-1 expression is decreased in skin tumors in Nrf2(+/+) mice; (4) Enhanced expression of c-Myc, Bcl-2, cyclin D1, beta-catenin, VEGF, Cox-2, and Bax is seen in all skin tumors; (5) UVB enhanced expression of inflammatory biomarkers in the skin of Nrf2(-/-) mice is substantially decreased compared with Nrf2(+/+) mice; (6) SFN induces cellular antioxidant proteins in MEFs (mouse embryonic fibroblast) and MEKs (mouse epidermal keratinocytes) of Nrf2 (+/+) but not of Nrf2 (- /-); (7) SFN blocks TPA-induced ear inflammation in C57BL/6J mice and not in Nrf2(-/-) mice; (8) Ursolic acid (UA), a natural triterpenoid with potent anti-inflammatory and cancer preventive activities inhibits TPA-induced ear edema and tumor promotion; (9) Increasing evidence suggests that epigenetics plays an important role in cancer development and progression including non-melanoma skin cancer; both UA and SFN modify CpG methylation of Nrf2 in JB6 mouse epidermal cell line; (10) Significant difference are observed in global DNA methylation profiles between DMBA/TPA papilloma vs normal skin and UVB-induced skin tumor vs non- irradiated skin analyzed by MeDIP-Seq analysis; and (11) UA and SFN inhibit TPA-induced JB6 transformation in soft agar. Based on the results summarized above we hypothesize that UA and SFN prevent skin carcinogenesis by altering epigenetic modifications with 3 specific aims: (1) To investigate the epigenetic events during in vivo skin cancer development and progression in B[a]P/TPA-induced skin carcinogenesis in Nrf2(+/+) vs Nrf2(-/-) C57BL6 mice, UVB-induced skin tumorigenesis in SKH-1 mice, and the cancer preventive efficacy coupled with epigenetic changes of UA and SFN; (2) To examine the epigenetic changes during transformation in vitro of mouse epidermal JB6 and human keratinocyte HaCaT cells and the effect of UA and SFN on these epigenetic changes; (3) To elucidate the molecular mechanisms involved in the epigenetic regulation of inflammatory/oxidative stress genes identified in Aims 1 and 2 by UA and SFN in mouse epidermal JB6 and human keratinocyte HaCaT cells. This study will advance our knowledge in developing better chemopreventive compounds for cancer chemoprevention clinical trials in skin cancer.
描述(由申请人提供):非黑色素瘤皮肤癌是美国最常见的癌症类型,每年新发病例超过100万例,而暴露于阳光(UV)和环境致癌物的增加似乎是主要的致病因素。本申请的长期目标是开发一种安全有效的策略,使用相对无毒的饮食癌症化学预防化合物来预防皮肤癌。这些研究的基本原理是基于本实验室和其他实验室的研究,表明:(1)萝卜硫素(SFN)分别在这些浆果和十字花科植物中大量存在,强烈抑制各种小鼠体内模型的皮肤致癌作用;(2)皮肤癌发生在Nrf 2的敲除中大大增强,Nrf 2是介导抗氧化应激/炎症反应的关键转录因子,并且重要的是,SFN在这些Nrf 2(-/-)小鼠中没有癌症保护作用;(3)在Nrf 2(+/+)小鼠的皮肤肿瘤中Nrf 2和Nrf 2靶向的HO-1表达降低;(4)在所有皮肤肿瘤中观察到c-Myc、Bcl-2、细胞周期蛋白D1、β-连环蛋白、VEGF、考克斯-2和Bax的表达增强;(5)与Nrf 2(+/+)小鼠相比,UVB增强的Nrf 2(-/-)小鼠皮肤中炎性生物标志物的表达显著降低;(6)SFN诱导MEFs中的细胞抗氧化蛋白(小鼠胚胎成纤维细胞)和MEK(7)SFN在C57 BL/6 J小鼠中阻断TPA诱导的耳部炎症,而在Nrf 2(-/-)小鼠中不阻断TPA诱导的耳部炎症;(8)熊果酸(UA)是一种天然三萜类化合物,具有有效的抗炎和癌症预防活性,可抑制TPA诱导的耳部水肿和肿瘤促进作用;(9)越来越多的证据表明表观遗传学在包括非黑色素瘤皮肤癌在内的癌症发生和进展中起重要作用; UA和SFN均修饰JB 6小鼠表皮细胞系中Nrf 2的CpG甲基化;(10)通过MeDIP-Seq分析,在DMBA/TPA乳头状瘤与正常皮肤之间以及UVB诱导的皮肤肿瘤与未照射的皮肤之间观察到全局DNA甲基化谱的显著差异;以及(11)UA和SFN抑制软琼脂中TPA诱导的JB 6转化。基于以上总结的结果,我们假设UA和SFN通过改变表观遗传修饰来预防皮肤癌发生,具有3个特定目的:(1)研究在Nrf 2(+/+)与Nrf 2(-/-)C57 BL 6小鼠中B[a]P/TPA诱导的皮肤癌发生、UVB诱导的SKH-1小鼠中的皮肤肿瘤发生、(2)研究小鼠表皮JB 6细胞和人角质形成细胞HaCaT细胞体外转化过程中的表观遗传学变化以及UA和SFN对这些表观遗传学变化的影响;(3)阐明炎症/炎症反应的表观遗传调控的分子机制。通过小鼠表皮JB 6和人角质形成细胞HaCaT细胞中的UA和SFN在目的1和2中鉴定的氧化应激基因。这项研究将促进我们的知识,在开发更好的化学预防化合物的癌症化学预防皮肤癌的临床试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ah-Ng Tony Kong其他文献
Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models
植物化学物对癌症的化学预防:潜在的分子靶点、生物标志物和动物模型
- DOI:
10.1111/j.1745-7254.2007.00694.x - 发表时间:
2007-09-01 - 期刊:
- 影响因子:8.400
- 作者:
Ki Han Kwon;Avantika Barve;Siwang Yu;Mou-Tuan Huang;Ah-Ng Tony Kong - 通讯作者:
Ah-Ng Tony Kong
Potent Inhibitory Effect of δ?Tocopherol on Prostate Cancer Cellsbr /Cultured in Vitro and Grown As Xenograft Tumors in Vivo
生育酚对体外培养的前列腺癌细胞和体内异种移植肿瘤的有效抑制作用
- DOI:
- 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
Hong Wang;Zhi Yun Du;Dongli Li;Kun Zhang;Ah-Ng Tony Kong;Robert S. DiPaola;Chung S. Yang;Allan H. Conney;Xi Zheng - 通讯作者:
Xi Zheng
Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells
天然饮食抗癌化学预防化合物:氧化还原介导的正常细胞细胞保护与肿瘤细胞细胞毒性中的差异信号机制
- DOI:
10.1111/j.1745-7254.2007.00549.x - 发表时间:
2007-04-01 - 期刊:
- 影响因子:8.400
- 作者:
Sujit Nair;Wenge Li;Ah-Ng Tony Kong - 通讯作者:
Ah-Ng Tony Kong
Induction of phase I, II and III drug metabolism/transport by xenobiotics
- DOI:
10.1007/bf02977789 - 发表时间:
2005-03-01 - 期刊:
- 影响因子:7.500
- 作者:
Changjiang Xu;Christina Yong-Tao Li;Ah-Ng Tony Kong - 通讯作者:
Ah-Ng Tony Kong
Signal transduction events elicited by natural products: Role of MAPK and caspase pathways in homeostatic response and induction of apoptosis
- DOI:
10.1007/bf02976458 - 发表时间:
2000-02-01 - 期刊:
- 影响因子:7.500
- 作者:
Ah-Ng Tony Kong;Rong Yu;Chi Chen;Sandhya Mandlekar;Thomas Primiano - 通讯作者:
Thomas Primiano
Ah-Ng Tony Kong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ah-Ng Tony Kong', 18)}}的其他基金
Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease
吲哚-3-甲醇/二吲哚柠檬烷和三萜类化合物预防前列腺炎症和相关疾病的表观遗传机制
- 批准号:
9120455 - 财政年份:2015
- 资助金额:
$ 35.46万 - 项目类别:
Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease
吲哚-3-甲醇/二吲哚柠檬烷和三萜类化合物预防前列腺炎症和相关疾病的表观遗传机制
- 批准号:
9136770 - 财政年份:2015
- 资助金额:
$ 35.46万 - 项目类别:
Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease
吲哚-3-甲醇/二吲哚柠檬烷和三萜类化合物预防前列腺炎症和相关疾病的表观遗传机制
- 批准号:
9761462 - 财政年份:2015
- 资助金额:
$ 35.46万 - 项目类别:
Curcuma Longa: epigenetic effects in prostate and colon cancer
姜黄:前列腺癌和结肠癌的表观遗传效应
- 批准号:
8234574 - 财政年份:2012
- 资助金额:
$ 35.46万 - 项目类别:
Curcuma Longa: epigenetic effects in prostate and colon cancer
姜黄:前列腺癌和结肠癌的表观遗传效应
- 批准号:
8722448 - 财政年份:2012
- 资助金额:
$ 35.46万 - 项目类别:
Curcuma Longa: epigenetic effects in prostate and colon cancer
姜黄:前列腺癌和结肠癌的表观遗传效应
- 批准号:
8913687 - 财政年份:2012
- 资助金额:
$ 35.46万 - 项目类别:
Curcuma Longa: epigenetic effects in prostate and colon cancer
姜黄:前列腺癌和结肠癌的表观遗传效应
- 批准号:
8538296 - 财政年份:2012
- 资助金额:
$ 35.46万 - 项目类别:
Curcuma Longa: epigenetic effects in prostate and colon cancer
姜黄:前列腺癌和结肠癌的表观遗传效应
- 批准号:
9122322 - 财政年份:2012
- 资助金额:
$ 35.46万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 35.46万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 35.46万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 35.46万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 35.46万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 35.46万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 35.46万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 35.46万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 35.46万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 35.46万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 35.46万 - 项目类别: